Screener / SEC EDGAR /CIK 0001616862 /10-K filed Feb 13, 2026, compared with Feb 13, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Materials · Paints & Coatings

Axalta Coating Systems Ltd. AXTA

Compare with peers Embed
Earnings releases

Latest results release: Oct 29, 2026

8-K item 2.02, exhibit 99

What AXTA's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Oct 29, 2026, AXTA reported $0.44 per share under GAAP and $0.63 on its own adjusted basis: the adjusted number is +43% above GAAP.

GAAP EPS $0.51, release Aug 1, 2024: year to $291 million with Adjusted EBITDA margin improving 400 basis points year over year to 21.5% ▪ Diluted EPS increased 89% year over year to $0.51 and Adjusted Diluted EPS increased 63% Adjusted EPS $0.57, release Aug 1, 2024: 400 basis points year over year to 21.5% ▪ Diluted EPS increased 89% year over year to $0.51 and Adjusted Diluted EPS increased 63% year over year to $0.57 ▪ Net leverage ratio of 2.6x ▪ Repurcha +12% 2024-08 GAAP EPS $0.46, release Oct 30, 2024: EBITDA of $291 million ▪ Adjusted EBITDA margin improved 220 basis points year over year to 22.1% ▪ Diluted EPS increased 39% year over year to $0.46 and Adjusted Diluted EPS increased 31% Adjusted EPS $0.59, release Oct 30, 2024: 220 basis points year over year to 22.1% ▪ Diluted EPS increased 39% year over year to $0.46 and Adjusted Diluted EPS increased 31% year over year to $0.59 ▪ Repurchased $50 million of common sha +28% 2024-10 GAAP EPS $1.78, release Feb 4, 2025: 220 basis points ▪ Record full year Adjusted EBITDA of $1,116 million, with Adjusted EBITDA margins of 21.2% ▪ Diluted EPS increased 47% to $1.78 and Adjusted Diluted EPS increased 40% Adjusted EPS $2.35, release Feb 4, 2025: EBITDA of $1,116 million, with Adjusted EBITDA margins of 21.2% ▪ Diluted EPS increased 47% to $1.78 and Adjusted Diluted EPS increased 40% to $2.35 Fourth Quarter 2024 Consolidated Financ +32% 2025-02 GAAP EPS $0.45, release May 7, 2025: an increase of 4% year over year ▪ Adjusted EBITDA margin improved 140 basis points year over year to 21.4% ▪ Diluted EPS increased 150% to $0.45 and Adjusted Diluted EPS increased 16% Adjusted EPS $0.59, release May 7, 2025: EBITDA margin improved 140 basis points year over year to 21.4% ▪ Diluted EPS increased 150% to $0.45 and Adjusted Diluted EPS increased 16% to $0.59, first quarter records ▪ Won two Edison +31% 2025-05 GAAP EPS $0.50, release Jul 30, 2025: for Adjusted EBITDA of $292 million ▪ Adjusted EBITDA margin expanded 90 basis points year over year to 22.4% ▪ Diluted EPS decreased 2% to $0.50 ▪ Record quarter for Adjusted Diluted E Adjusted EPS $0.64, release Jul 30, 2025: margin expanded 90 basis points year over year to 22.4% ▪ Diluted EPS decreased 2% to $0.50 ▪ Record quarter for Adjusted Diluted EPS of $0.64, an increase of 5% ▪ Cash provided by o +28% 2025-07 GAAP EPS $0.51, release Oct 28, 2025: for Adjusted EBITDA of $294 million ▪ Adjusted EBITDA margin expanded 70 basis points year over year to 22.8% ▪ Diluted EPS increased 11% to $0.51 ▪ Record quarter for Adjusted Diluted E Adjusted EPS $0.67, release Oct 28, 2025: margin expanded 70 basis points year over year to 22.8% ▪ Diluted EPS increased 11% to $0.51 ▪ Record quarter for Adjusted Diluted EPS of $0.67, an increase of 6% ▪ Executed $100 mill +31% 2025-10 GAAP EPS $0.28, release Feb 10, 2026: of 4.8% ▪ Adjusted EBITDA of $272 million ▪ Adjusted EBITDA margin of 21.5%, a 50 basis point increase year over year ▪ Diluted EPS of $0.28 and Adjusted Diluted EPS of $0.59 ▪ Rec Adjusted EPS $0.59, release Feb 10, 2026: million ▪ Adjusted EBITDA margin of 21.5%, a 50 basis point increase year over year ▪ Diluted EPS of $0.28 and Adjusted Diluted EPS of $0.59 ▪ Record fourth quarter cash provided b +111% 2026-02 GAAP EPS $0.42, release Apr 30, 2026: of $91 million with a net income margin of 7.3% ▪ Adjusted EBITDA of $259 million and Adjusted EBITDA margin of 20.6% ▪ Diluted EPS of $0.42 and Adjusted Diluted EPS of $0.56 ▪ Rec Adjusted EPS $0.56, release Apr 30, 2026: margin of 7.3% ▪ Adjusted EBITDA of $259 million and Adjusted EBITDA margin of 20.6% ▪ Diluted EPS of $0.42 and Adjusted Diluted EPS of $0.56 ▪ Record first quarter cash provided by +33% 2026-04 GAAP EPS $0.41, release Jul 28, 2026: income margin of 6.6% ▪ Record quarter for Adjusted EBITDA of $305 million with an Adjusted EBITDA margin of 22.7% ▪ Diluted EPS of $0.41 ▪ Record quarter for Adjusted Diluted E Adjusted EPS $0.72, release Jul 28, 2026: EBITDA of $305 million with an Adjusted EBITDA margin of 22.7% ▪ Diluted EPS of $0.41 ▪ Record quarter for Adjusted Diluted EPS of $0.72, an increase of 13% year over year ▪ Ca +76% 2026-07 GAAP EPS $0.44, release Oct 29, 2026: $95 million and net income margin of 7.2% ▪ Adjusted EBITDA of $282 million with an Adjusted EBITDA margin of 21.5% ▪ Diluted EPS of $0.44 ▪ Adjusted Diluted EPS of $0.63 ▪ Cash Adjusted EPS $0.63, release Oct 29, 2026: margin of 7.2% ▪ Adjusted EBITDA of $282 million with an Adjusted EBITDA margin of 21.5% ▪ Diluted EPS of $0.44 ▪ Adjusted Diluted EPS of $0.63 ▪ Cash provided by operating activities +43% 2026-10
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
The company's words, latest release
$95 million and net income margin of 7.2% ▪ Adjusted EBITDA of $282 million with an Adjusted EBITDA margin of 21.5% ▪ Diluted EPS of $0.44 ▪ Adjusted Diluted EPS of $0.63 ▪ Cash release
margin of 7.2% ▪ Adjusted EBITDA of $282 million with an Adjusted EBITDA margin of 21.5% ▪ Diluted EPS of $0.44 ▪ Adjusted Diluted EPS of $0.63 ▪ Cash provided by operating activities release

What the company says its adjusted numbers leave out:

Adjusted net income, which excludes merger and acquisition-related expenses, decreased 6% year over year to $136 million driven by lower volumes in Performance Coatings and higher raw material and freight costs, partially offset by reduced operating expenses, favorable price mix and lower interest expense. release Oct 29, 2026

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Oct 29, 2026 · EX-99

1050 Constitution Colleen Lubic Media Contact

Open on SEC

Exhibit 99 News Release Axalta Coating Systems Investor Contact 1050 Constitution Colleen Lubic Media Contact Avenue D +1 610-999-9407 axalta-media-relat… Philadelphia, PA Colleen.Lubic@axa… 19112 USA

PHILADELPHIA, PA, October 29, 2026 - Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the third quarter ended September 30, 2026.

▪ Cash provided by operating activities of $135 million, in line with prior year

“Axalta delivered another quarter of revenue growth, strong cash generation and robust profitability despite a more challenging operating environment,” said Chris Villavarayan, Chief Executive Officer and President of Axalta. “We maintained Adjusted EBITDA margin above 20%, further strengthened our balance sheet and achieved record quarterly net sales in Mobility Coatings. As we look ahead, we remain focused on disciplined execution and are confident in the significant value creation opportunity associated with our proposed combination with AkzoNobel.”

Third quarter 2026 net sales increased 2% to $1.3 billion driven by volume growth in three out of four regions, favorable foreign currency translation, contributions from acquisitions and positive price mix, partially offset by volume declines primarily in Europe.

Net income decreased by $15 million year over year to $95 million resulting in a net income margin of 7.2%. The decrease was primarily driven by an incremental $14 million in merger and acquisition-related expenses in the current-year period. Adjusted net income, which excludes merger and acquisition-related expenses, decreased 6% year over year to $136 million driven by lower volumes in Performance Coatings and higher raw material and freight costs, partially offset by reduced operating expenses, favorable price mix and lower interest expense.

Adjusted EBITDA was $282 million, a decrease of 4% compared to the prior-year period, resulting in an Adjusted EBITDA margin of 21.5%. Diluted EPS was $0.44 compared to $0.51 in the prior-year period, reflecting lower volumes in Performance Coatings and higher merger and acquisition-related expenses. Adjusted Diluted EPS was $0.63, down 6% year over year, as lower volumes and higher variable costs were partially offset by lower interest expense resulting from the Company's continued deleveraging efforts.

Cash provided by operating activities was $135 million, in line with the prior- year period, and free cash flow increased 3% year over year to $92 million, inclusive of approximate ly $21 million of incremental merger and acquisition- related cash costs incurred during the quarter.

Performance Coatings net sales were $818 million in the third quarter, dow n $10 million year over year, as lower Refinish volumes in Europe more than offset favorable foreign currency translation, contributions from acquisitions and positive price mix. Outside of Europe, demand trends across Performance Coatings remained generally stable, with net sales down low single digits in North America and up high single digits in both Latin America and Asia Pacific, continuing the growth momentum established over the last four quarters in such regions. 1 Refinish net sales declined 2% year over year to $504 million, primarily driven by lower volumes in Europe, partially offset by contributions from acquisitions and favorable price mix. Industrial net sales increased by 1% year over year to $314 million, primarily driven by volume growth in Asia Pacific.

Performance Coatings Adjusted EBITDA was $188 million compared with $211 million in the prior-year period. The decrease was driven by lower volumes, variable cost inflation and investments supporting recently awarded business wins, partially offset by lower operating expenses, pricing actions and contributions from acquisitions. Adjusted EBITDA margin was 23.0%, compared to 25.5% in the prior-year period.

Mobility Coatings achieved record quarterly net sales of $493 million, up 7% year over year. Light Vehicle net sales were up 2%, driven primarily by favorable foreign currency translation. Commercial Vehicle net sales increased 24% year over year to $119 million, driven by volume growth resulting from an increase in Class 8 production in North America.

Mobility Coatings delivered Adjusted EBITDA of $94 million, a third quarter record, with Adjusted EBITDA margin of 19.0% refle cting 100 basis points of margin expansion year over year. Stronger volumes and lower operating expenses more than offset variable cost inflation and unfavorable price mix.

(in millions, except %’s and per share Projection data) Item Q4 2026 FY 2026 Net Sales (YoY % growth) ~FLAT LSD% Adjusted EBITDA $254 - $264 $1,100 - $1,110 Adjusted Diluted EPS ~$0.55 ~$2.45 Free Cash Flow(1) ~$450 Depreciation and Amortization $310 Tax Rate, As Adjusted ~24% Diluted Shares Outstanding ~215 Interest Expense ~$150 Capital Expenditures ~$200

Axalta does not provide a reconciliation for non-GAAP estimates for Adjusted EBITDA, Adjusted Diluted EPS, Free Cash Flow or tax rate, as adjusted, on a forward-looking basis because the information necessary to calculate a meaningful or accurate estimation of reconciling items is not available without unreasonable effort. See “Non-GAAP Financial Measures” for more information.

As previously announced, Axalta will hold a conference call to discuss its third quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 a.m. ET. A live webcast of the conference call will be available online at www.axalta.com/investorcall . A replay of the webcast will be posted shortly after the call and will remain accessible through October 29, 2027. The dial-in phone number for the conference call is 1-800-445-7795 and the conference ID is AXALTA. For those unable to participate, a replay will be available through November 5, 2026. The replay dial-in number is +1-844-512-2921. The replay passcode is 11162641.

This release may contain certain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 regarding Axalta and its subsidiaries including, but not limited to, our outlook and/or guidance, which includes net sales growth, Adjusted EBITDA, Adjusted Diluted EPS, Free Cash Flow, depreciation and amortization, tax rate, as adjusted, diluted shares outstanding, interest expense and capital expenditures and statements regarding the proposed merger of equals (the “Proposed Merger”) with Akzo Nobel N.V. (“AkzoNobel”) (including our ability to consummate the Proposed Merger and realize the anticipated benefits thereof). Axalta has identified some of these forward-looking statements with words 2 such as “outlook,” “proposed,” “opportunity,” “confident,” “anticipated,” “momentum,” and “projection,” and the negative of these words or other comparable or similar terminology. All of these statements are based on management’s expectations as well as estimates and assumptions prepared by management that, although they believe to be reasonable, are inherently uncertain. These statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental (including related to any new or existing tariffs imposed by the U.S. and any retaliatory actions from other countries), geopolitical (including the current conflict in the Middle East and related effects on raw material and freight prices, as well as mitigation strategies developed in response thereto) and technological factors outside of Axalta’s control, as well as risks related to the execution of, and assumptions underlying, our tariff mitigation strategies, our capital allocation strategy and future share repurchases, our previously-announced global transformation initiative, our previously-announced three-year 2024-2026 strategy, the Proposed Merger (including our ability to consummate the Proposed Merger and realize the anticipated benefits thereof) and our planned divestiture of our North America Building Products business that may cause its business, industry, strategy, financing activities or actual results to differ materially. More information on potential factors that could affect Axalta’s financial results is available in “Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” within Axalta’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and in other documents that we have filed with, or furnished to, the U.S. Securities and Exchange Commission (the “SEC”). More information on these risks, as well as other risks associated with the Proposed Merger, are also discussed in the definitive proxy statement/prospectus relating to the Proposed Merger, which was filed with the SEC on June 24, 2026. Axalta undertakes no obligation to update or revise any of the forward-looking statements contained herein, whether as a result of new information, future events or otherwise.

This release includes financial information that is not presented in accordance with generally accepted accounting principles in the United States (“GAAP”), including Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, Free Cash Flow, total net leverage ratio (or “total net leverage”), tax rate, as adjusted, and Adjusted EBIT. Management uses Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, tax rate, as adjusted, and Adjusted EBIT in the analysis of our financial and operating performance because they assist in the evaluation of underlying trends in our business. Management uses Free Cash Flow and total net leverage ratio in the analysis of (1) our liquidity, (2) our ability to incur and service our debt and (3) strategic capital allocation decisions. Adjusted EBITDA, Adjusted Diluted EPS, adjusted net income and Adjusted EBIT consist of EBITDA, Diluted EPS, net income attributable to common shareholders and EBIT, respectively, adjusted for (i) certain non-cash items included within net income, (ii) certain items Axalta does not believe are indicative of ongoing operating performance or (iii) certain nonrecurring, unusual or infrequent items that have not otherwise occurred within the last two years or we believe are not reasonably likely to recur within the next two years. Free Cash Flow consists of cash provided by (used for) operating activities less purchase of property, plant and equipment plus interest proceeds on swaps designated as net investment hedges. Total net leverage ratio consists of net debt divided by Adjusted EBITDA, with net debt defined as total debt less cash and cash equivalents. We believe that making the foregoing adjustments provides investors meaningful information to understand our operating results and ability to analyze financial and business trends on a period-to-period basis. The non-GAAP financial measures used by Axalta may differ from similarly titled measures reported by other companies. Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, Free Cash Flow, total net leverage ratio, tax rate, as adjusted, and Adjusted EBIT should not be considered as alternatives to net sales, net income (loss), income (loss) from operations or any other financial measures derived in accordance with GAAP. These non-GAAP financial measures have important limitations as analytical tools and should be considered in conjunction with, and not as substitutes for, our results as reported under GAAP. This release includes a reconciliation of certain non-GAAP financial measures with the most directly comparable financial measures calculated in accordance with GAAP. Axalta does not provide a reconciliation for Adjusted EBITDA, Adjusted Diluted EPS, tax rate, as adjusted, or Free Cash Flow on a forward-looking basis because the information necessary to calculate a meaningful or accurate estimation of reconciling items is not available without unreasonable effort. For example, such reconciling items include the impact of foreign currency exchange gains or losses, gains or losses that are unusual or nonrecurring in nature, as well as discrete taxable events. These items are uncertain, depend on various factors and may have a substantial and unpredictable impact on our GAAP results.

The primary measure of segment operating performance is Adjusted EBITDA, which is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts and prior year financial results and that management believes reflects Axalta’s core operating performance. As we do not measure segment operating performance 3 based on net income, a reconciliation of this non-GAAP financial measure with the most directly comparable financial measure calculated in accordance with GAAP is not available.

All capitalized terms contained within this release that are not otherwise defined herein have been previously defined in our filings with the SEC.

Certain amounts may not foot or crossfoot due to rounding. Additionally, certain percentages may not recalculate due to rounding.

This communication is not for release, publication, or distribution, in whole or in part, in or into, directly or indirectly, any jurisdiction in which such release, publication, or distribution would be unlawful.

This communication is not a prospectus and the information in this communication is not intended to be complete. This communication is for informational purposes only and is not intended to be and shall not constitute a solicitation of any vote or approval, or an offer to buy or sell, or the solicitation of an offer to buy or sell, any securities, or an invitation or recommendation to subscribe for, acquire or buy securities of Axalta or AkzoNobel or any other financial products or securities, in any place or jurisdiction, nor shall there be any offer, solicitation or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended (the “Securities Act”).

Any decision to purchase, subscribe for, otherwise acquire, sell or otherwise dispose of any securities must be made only on the basis of the information contained in and incorporated by reference into the prospectus with respect to the shares to be allotted by AkzoNobel in the Proposed Merger, which was published on June 24, 2026 and supplemented on July 22, 2026.

The distribution of this communication may, in some countries, be restricted by law or regulation. Accordingly, persons who come into possession of this document should inform themselves of and observe these restrictions. To the fullest extent permitted by applicable law, Axalta and AkzoNobel disclaim any responsibility or liability for the violation of any such restrictions by any person. Neither Axalta, nor AkzoNobel, nor any of their advisors assume any responsibility for any violation by any person of any of these restrictions. Shareholders of Axalta and AkzoNobel, respectively, with any doubt as to their position should consult an appropriate professional advisor without delay.

This communication is addressed to and directed only at (i) persons who are outside the United Kingdom, (ii) persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (iii) persons falling within Article 49(2)(a) to (d) of the Order, or (iv) persons to whom it may otherwise lawfully be communicated pursuant to the Order (all such persons together being referred to as, “Relevant Persons”). This communication is directed only at Relevant Persons. Other persons should not act or rely on this communication or any of its contents. Any investment or investment activity to which this communication relates is available only to Relevant Persons and will be engaged in only with such persons. Solicitations resulting from this communication will only be responded to if the person concerned is a Relevant Person.

In connection with the Proposed Merger between Axalta and AkzoNobel, AkzoNobel filed with the SEC a registration statement on Form F-4 on May 27, 2026, as amended on June 18, 2026, which included a proxy statement of Axalta that also constitutes a prospectus with respect to the shares to be offered by AkzoNobel in the Proposed Merger. The registration statement was declared effective by the SEC on June 23, 2026. In connection with the proposed transaction, on June 24, 2026, Axalta filed with the SEC a definitive proxy statement and, on or about June 24, 2026, Axalta commenced mailing the definitive proxy statement to its holders of record as of June 11, 2026. On August 5, 2026, shareholders at the Extraordinary General Meeting of AkzoNobel and the Special General Meeting of Axalta, respectively, voted in favor of all resolutions related to the Proposed Merger. Each of Axalta and AkzoNobel will also file other relevant documents in connection with the Proposed Merger. This communication is not a substitute for any registration statement, proxy statement/prospectus or other documents Axalta and/or AkzoNobel may file with the SEC or any other competent regulator in connection with the Proposed Merger. This communication does not contain all the information that should be considered concerning the Proposed Merger and is not intended to form the basis of any investment decision or any other decision in respect of the Proposed Merger. BEFORE MAKING ANY VOTING OR INVESTMENT DECISIONS, INVESTORS, STOCKHOLDERS AND 4 SHAREHOLDERS OF AXALTA AND AKZONOBEL ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PROXY STATEMENT/PROSPECTUS, AS APPLICABLE, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, IN CONNECTION WITH THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE, AS THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT AXALTA, AKZONOBEL, THE PROPOSED TRANSACTION AND RELATED MATTERS. The registration statement and proxy statement/prospectus and other relevant documents filed by Axalta and AkzoNobel with the SEC are available free of charge at the SEC’s website at www.sec.gov. In addition, investors and shareholders will be able to obtain free copies of the proxy statement/prospectus and other documents filed with the SEC from Axalta’s investor relations webpage at https://ir.axalta.com/sec-filings/all-sec-filings or from AkzoNobel’s investor relations webpage at https://www.akzonobel.com/en/investors/all-sec-filings.

The contents of this communication should not be construed as financial, legal, business, investment, tax or other professional advice. Each recipient should consult with its own professional advisors for any such matter and advice

Axalta is a global leader in the coatings industry, providing customers with innovative, colorful, beautiful and sustainable coatings solutions. From light vehicles, commercial vehicles and refinish applications to electric motors, building facades and other industrial applications, our coatings are designed to prevent corrosion, increase productivity and enhance durability. With more than 150 years of experience in the coatings industry, the global team at Axalta continues to find ways to serve our more than 100,000 customers in over 140 countries better every day with the finest coatings, application systems and technology. For more information visit axalta.com and follow us @axalta on X. 5

Financ… Statem… Tables AXALTA COATING SYSTEMS LTD. Conden… Consol… Statem… of Operat… (Unaud… (In millio… except per share data) Three Nine Months Months Ended Ended September Septemb… 30, 30, 2026 2025 2026 2025 Net $ 1,311 $ 1,288 $ 3,911 $ 3,855 sales Cost of goods 877 838 2,596 2,515 sold Sellin… general and 201 197 614 607 admini… expens… Other operat… 24 6 92 32 charges Resear… and 18 18 54 55 develo… expens… Amorti… of 26 25 77 73 acquir… intang… Income from 165 204 478 573 operat… Intere… expens… 37 45 112 134 net Other expense — 4 -1 12 (incom… net Income before 128 155 367 427 income taxes Provis… for 33 45 92 108 income taxes Net 95 110 275 319 income Less: Net income attrib… — — 1 1 to noncon… intere… Net income attrib… $ 95 $ 110 $ 274 $ 318 to common shareh… Basic net income $ 0.44 $ 0.51 $ 1.28 $ 1.47 per share Diluted net income $ 0.44 $ 0.51 $ 1.28 $ 1.46 per share Basic weight… average 214.0 215.0 213.9 216.9 shares outsta… Diluted weight… average 215.1 215.9 214.8 217.9 shares outsta…

AXALTA COATING SYSTEMS LTD. Condensed Consolidated Balance Sheets (Unaudited) (In millions, except per share data) Assets Current assets: September 30, 2026 December 31, 2025 ────────────────────────────────────────────────────────────────────────────── Cash and cash $ 650 $ 657 equivalents Restricted cash 6 3 Accounts and notes receivable, 1,366 1,229 net Inventories 849 756 Prepaid expenses and other current 192 170 assets Total current 3,063 2,815 assets Property, plant and equipment, 1,319 1,299 net Goodwill 1,762 1,795 Identifiable 1,056 1,147 intangibles, net Other assets 547 543 Total assets $ 7,747 $ 7,599 Liabilities, Shareholders’ Equity Current liabilities: Accounts payable $ 780 $ 637 Current portion 519 20 of borrowings Other accrued 701 712 liabilities Total current 2,000 1,369 liabilities Long-term 2,476 3,179 borrowings Accrued pensions 225 238 Deferred income 182 171 taxes Other liabilities 198 249 Total liabilities 5,081 5,206 Shareholders’ equity: Common shares, $1.00 par, 1,000.0 shares authorized, 255.7 and 255.1 shares issued at 256 255 September 30, 2026 and December 31, 2025, respectively Capital in excess 1,637 1,621 of par Retained earnings 2,329 2,055 Treasury shares, at cost, 41.7 shares at both September -1,202 -1,202 30, 2026 and December 31, 2025 Accumulated other comprehensive -400 -383 loss Total Axalta shareholders’ 2,620 2,346 equity Noncontrolling 46 47 interests Total shareholders’ 2,666 2,393 equity Total liabilities and shareholders’ $ 7,747 $ 7,599 equity

AXALTA COATING SYSTEMS LTD. Condensed Consolidated Statements of Cash Flows (Unaudited) Nine Months Ended (In millions) September 30, Operating activities: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 275 $ 319 Adjustment to reconcile net income to cash provided by operating activities: Depreciation and amortization 233 218 Amortization of deferred financing costs 6 6 and original issue discount Deferred income taxes 24 28 Realized and unrealized foreign exchange -8 31 (gains) losses, net Stock-based compensation 23 19 Interest income on swaps designated as -9 -9 net investment hedges Other non-cash, net -2 8 Changes in operating assets and liabilities: Trade accounts and notes receivable -132 -48 Inventories -99 -53 Prepaid expenses and other assets -75 -132 Accounts payable 146 -15 Other accrued liabilities 2 -71 Other liabilities -29 4 Cash provided by operating 355 305 activities Investing activities: Acquisitions, net of cash acquired -8 -6 Purchase of property, plant and -144 -138 equipment Interest proceeds on swaps designated as 9 9 net investment hedges Proceeds received on loans to 8 6 customers Other investing activities, net -3 7 Cash used for investing activities -138 -122 Financing activities: Payments on long-term borrowings -211 -25 Purchases of common stock — -165 Net cash flows associated with -7 -3 stock-based awards Other financing activities, net -3 -2 Cash used for financing activities -221 -195 Decrease in cash -4 -12 Effect of exchange rate changes on — 26 cash Cash at beginning of period 660 596 Cash at end of period $ 656 $ 610 Cash at end of period reconciliation: Cash and cash equivalents $ 650 $ 606 Restricted cash 6 4 Cash at end of period $ 656 $ 610

8 The following table reconciles net income to EBITDA, Adjusted EBITDA and segment Adjusted EBITDA for the periods presented (in millions):

Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other (a) employee-related costs associated with restructuring programs and other employee-related costs. We do not consider these amounts indicative of our ongoing operating performance. Represents merger and acquisition-related expenses, including costs (b) related to financial, tax and legal advisory services, associated with both consummated and unconsummated transactions, all of which we do not consider indicative of our ongoing operating performance. Represents costs related to the closure of certain manufacturing (c) sites, including impairment charges, which we do not consider indicative of our ongoing operating performance. Represents foreign exchange losses resulting from the remeasurement (d) of assets and liabilities denominated in foreign currencies, net of the impacts of our foreign currency instruments used to hedge our balance sheet exposures. (e) Represents the non-cash, non-service cost components of long-term employee benefit costs. (f) Represents non-cash impacts associated with stock-based compensation. Represents non-recurring income related to the sales of certain fixed (g) assets, which are not considered indicative of our ongoing performance. Represents (benefits) costs for certain non-operational or non-cash (h) (gains) losses, net, unrelated to our core business and which we do not consider indicative of our ongoing operating performance.

9 The following table reconciles net income to adjusted net income for the periods presented (in millions, except per share data):

Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other (a) employee-related costs associated with restructuring programs and other employee-related costs. We do not consider these amounts indicative of our ongoing operating performance. Represents merger and acquisition-related expenses, including costs (b) related to financial, tax and legal advisory services, associated with both consummated and unconsummated transactions, all of which we do not consider indicative of our ongoing operating performance. Represents incremental depreciation expense resulting from truncated useful lives of the assets impacted by our manufacturing footprint (c) assessments and costs related to the closure of certain manufacturing sites, including impairment charges, which we do not consider indicative of our ongoing operating performance. Represents (benefits) costs for certain non-operational or non-cash (d) (gains) losses, net, unrelated to our core business and which we do not consider indicative of our ongoing operating performance. (e) Represents non-cash amortization expense for intangible assets acquired through business combinations or asset acquisitions. The income tax impacts are determined using the applicable rates in the taxing jurisdictions in which expense or income occurred and includes both current and deferred income tax expense (benefit) based (f) on the nature of the non-GAAP performance measure. Additionally, the income tax impact includes the removal of discrete income tax impacts within our effective tax rate which were benefits of $0 million and $12 million and expenses of $10 million and $6 million for the three and nine months ended September 30, 2026 and 2025, respectively.

10 The following table reconciles cash provided by operating activities to free cash flow for the periods presented (in millions):

11 The following table reconciles income from operations to adjusted EBIT for the periods presented (in millions):

Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other (a) employee-related costs associated with restructuring programs and other employee-related costs. We do not consider these amounts indicative of our ongoing operating performance. Represents merger and acquisition-related expenses, including costs (b) related to financial, tax and legal advisory services, associated with both consummated and unconsummated transactions, all of which we do not consider indicative of our ongoing operating performance. Represents incremental depreciation expense resulting from truncated useful lives of the assets impacted by our manufacturing footprint (c) assessments and costs related to the closure of certain manufacturing sites, including impairment charges, which we do not consider indicative of our ongoing operating performance. Represents (benefits) costs for certain non-operational or non-cash (d) (gains) losses, net, unrelated to our core business and which we do not consider indicative of our ongoing operating performance. (e) Represents non-cash amortization expense for intangible assets acquired through business combinations or asset acquisitions.

Full text with the tables
                                                                                
                                                                    Exhibit 99  
  News Release                                                                  
  Axalta Coating                                                                
  Systems              Investor Contact                                         
  1050 Constitution    Colleen Lubic         Media Contact                      
  Avenue               D +1 610-999-9407     axalta-media-relat…                
  Philadelphia, PA     Colleen.Lubic@axa…                                       
  19112                                                                         
  USA                                                                           
                                                                                
                                                                                
  Immediate Release                                                             
                                                                                
                                                                                
   Axalta Releases Third Quarter 2026 Results                                   
                                                                                
PHILADELPHIA, PA, October 29, 2026 - Axalta Coating Systems Ltd. (NYSE:AXTA)
(“Axalta”), a leading global coatings company, announced its financial results
for the third quarter ended September 30, 2026.

Third Quarter 2026 Highlights:

▪ Net sales of $1.3 billion, an increase of 2% year over year

▪ Record quarter for Mobility net sales

▪ Net income of $95 million and net income margin of 7.2%

▪ Adjusted EBITDA of $282 million with an Adjusted EBITDA margin of 21.5%

▪ Diluted EPS of $0.44

▪ Adjusted Diluted EPS of $0.63

▪ Cash provided by operating activities of $135 million, in line with prior year

▪ Free cash flow of $92 million, up 3% year over year

▪ Total net leverage of 2.1x, the lowest in Axalta’s history

“Axalta delivered another quarter of revenue growth, strong cash generation and
robust profitability despite a more challenging operating environment,” said
Chris Villavarayan, Chief Executive Officer and President of Axalta. “We
maintained Adjusted EBITDA margin above 20%, further strengthened our balance
sheet and achieved record quarterly net sales in Mobility Coatings. As we look
ahead, we remain focused on disciplined execution and are confident in the
significant value creation opportunity associated with our proposed combination
with AkzoNobel.”
                                                                                
   Third Quarter 2026 Consolidated Financial Results                            
                                                                                
Third quarter 2026 net sales increased 2% to $1.3 billion driven by volume
growth in three out of four regions, favorable foreign currency translation,
contributions from acquisitions and positive price mix, partially offset by
volume declines primarily in Europe.

Net income decreased by $15 million year over year to $95 million resulting in a
net income margin of 7.2%. The decrease was primarily driven by an incremental
$14 million in merger and acquisition-related expenses in the current-year
period. Adjusted net income, which excludes merger and acquisition-related
expenses, decreased 6% year over year to $136 million driven by lower volumes in
Performance Coatings and higher raw material and freight costs, partially offset
by reduced operating expenses, favorable price mix and lower interest expense.

Adjusted EBITDA was $282 million, a decrease of 4% compared to the prior-year
period, resulting in an Adjusted EBITDA margin of 21.5%. Diluted EPS was $0.44
compared to $0.51 in the prior-year period, reflecting lower volumes in
Performance Coatings and higher merger and acquisition-related expenses.
Adjusted Diluted EPS was $0.63, down 6% year over year, as lower volumes and
higher variable costs were partially offset by lower interest expense resulting
from the Company's continued deleveraging efforts.

Cash provided by operating activities was $135 million, in line with the prior-
year period, and free cash flow increased 3% year over year to $92 million,
inclusive of approximate ly $21 million of incremental merger and acquisition-
related cash costs incurred during the quarter.
                                                                                
   Discussion of Segment Results                                                
                                                                                
Performance Coatings net sales were $818 million in the third quarter, dow n $10
million year over year, as lower Refinish volumes in Europe more than offset
favorable foreign currency translation, contributions from acquisitions and
positive price mix. Outside of Europe, demand trends across Performance Coatings
remained generally stable, with net sales down low single digits in North
America and up high single digits in both Latin America and Asia Pacific,
continuing the growth momentum established over the last four quarters in such
regions.
                                       1                                        
Refinish net sales declined 2% year over year to $504 million, primarily driven
by lower volumes in Europe, partially offset by contributions from acquisitions
and favorable price mix. Industrial net sales increased by 1% year over year to
$314 million, primarily driven by volume growth in Asia Pacific.

Performance Coatings Adjusted EBITDA was $188 million compared with $211 million
in the prior-year period. The decrease was driven by lower volumes, variable
cost inflation and investments supporting recently awarded business wins,
partially offset by lower operating expenses, pricing actions and contributions
from acquisitions. Adjusted EBITDA margin was 23.0%, compared to 25.5% in the
prior-year period.

Mobility Coatings achieved record quarterly net sales of $493 million, up 7%
year over year. Light Vehicle net sales were up 2%, driven primarily by
favorable foreign currency translation. Commercial Vehicle net sales increased
24% year over year to $119 million, driven by volume growth resulting from an
increase in Class 8 production in North America.

Mobility Coatings delivered Adjusted EBITDA of $94 million, a third quarter
record, with Adjusted EBITDA margin of 19.0% refle cting 100 basis points of
margin expansion year over year. Stronger volumes and lower operating expenses
more than offset variable cost inflation and unfavorable price mix.
                                                                                
  Fourth Quarter and Full Year 2026 Outlook                                     
                                                                                
                                                                            
  (in millions, except %’s and per share    Projection                      
  data)                                                                     
  Item                                      Q4 2026                FY 2026  
  Net Sales (YoY % growth)                  ~FLAT                     LSD%  
  Adjusted EBITDA                           $254 - $264    $1,100 - $1,110  
  Adjusted Diluted EPS                      ~$0.55                  ~$2.45  
  Free Cash Flow(1)                                                  ~$450  
  Depreciation and Amortization                                       $310  
  Tax Rate, As Adjusted                                               ~24%  
  Diluted Shares Outstanding                                          ~215  
  Interest Expense                                                   ~$150  
  Capital Expenditures                                               ~$200  
                                                                            
LSD = low single digit percentage

(1) Includes ~$80M of merger and acquisition-related cash costs

Axalta does not provide a reconciliation for non-GAAP estimates for Adjusted
EBITDA, Adjusted Diluted EPS, Free Cash Flow or tax rate, as adjusted, on a
forward-looking basis because the information necessary to calculate a
meaningful or accurate estimation of reconciling items is not available without
unreasonable effort. See “Non-GAAP Financial Measures” for more information.
                                                                                
  Conference Call Information                                                   
                                                                                
As previously announced, Axalta will hold a conference call to discuss its third
quarter 2026 financial results on Thursday, October 29, 2026, at 8:00 a.m. ET. A
live webcast of the conference call will be available online at
www.axalta.com/investorcall . A replay of the webcast will be posted shortly
after the call and will remain accessible through October 29, 2027. The dial-in
phone number for the conference call is 1-800-445-7795 and the conference ID is
AXALTA. For those unable to participate, a replay will be available through
November 5, 2026. The replay dial-in number is +1-844-512-2921. The replay
passcode is 11162641.

Cautionary Statement Concerning Forward-Looking Statements

This release may contain certain forward-looking statements within the meaning
of the U.S. Private Securities Litigation Reform Act of 1995 regarding Axalta
and its subsidiaries including, but not limited to, our outlook and/or guidance,
which includes net sales growth, Adjusted EBITDA, Adjusted Diluted EPS, Free
Cash Flow, depreciation and amortization, tax rate, as adjusted, diluted shares
outstanding, interest expense and capital expenditures and statements regarding
the proposed merger of equals (the “Proposed Merger”) with Akzo Nobel N.V.
(“AkzoNobel”) (including our ability to consummate the Proposed Merger and
realize the anticipated benefits thereof). Axalta has identified some of these
forward-looking statements with words
                                       2                                        
such as “outlook,” “proposed,” “opportunity,” “confident,” “anticipated,”
“momentum,” and “projection,” and the negative of these words or other
comparable or similar terminology. All of these statements are based on
management’s expectations as well as estimates and assumptions prepared by
management that, although they believe to be reasonable, are inherently
uncertain. These statements involve risks and uncertainties, including, but not
limited to, economic, competitive, governmental (including related to any new or
existing tariffs imposed by the U.S. and any retaliatory actions from other
countries), geopolitical (including the current conflict in the Middle East and
related effects on raw material and freight prices, as well as mitigation
strategies developed in response thereto) and technological factors outside of
Axalta’s control, as well as risks related to the execution of, and assumptions
underlying, our tariff mitigation strategies, our capital allocation strategy
and future share repurchases, our previously-announced global transformation
initiative, our previously-announced three-year 2024-2026 strategy, the Proposed
Merger (including our ability to consummate the Proposed Merger and realize the
anticipated benefits thereof) and our planned divestiture of our North America
Building Products business that may cause its business, industry, strategy,
financing activities or actual results to differ materially. More information on
potential factors that could affect Axalta’s financial results is available in
“Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” within Axalta’s most
recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and in
other documents that we have filed with, or furnished to, the U.S. Securities
and Exchange Commission (the “SEC”). More information on these risks, as well as
other risks associated with the Proposed Merger, are also discussed in the
definitive proxy statement/prospectus relating to the Proposed Merger, which was
filed with the SEC on June 24, 2026. Axalta undertakes no obligation to update
or revise any of the forward-looking statements contained herein, whether as a
result of new information, future events or otherwise.
                                                                                
   Non-GAAP Financial Measures                                                  
                                                                                
This release includes financial information that is not presented in accordance
with generally accepted accounting principles in the United States (“GAAP”),
including Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS,
adjusted net income, Free Cash Flow, total net leverage ratio (or “total net
leverage”), tax rate, as adjusted, and Adjusted EBIT. Management uses Adjusted
EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, tax
rate, as adjusted, and Adjusted EBIT in the analysis of our financial and
operating performance because they assist in the evaluation of underlying trends
in our business. Management uses Free Cash Flow and total net leverage ratio in
the analysis of (1) our liquidity, (2) our ability to incur and service our debt
and (3) strategic capital allocation decisions. Adjusted EBITDA, Adjusted
Diluted EPS, adjusted net income and Adjusted EBIT consist of EBITDA, Diluted
EPS, net income attributable to common shareholders and EBIT, respectively,
adjusted for (i) certain non-cash items included within net income, (ii) certain
items Axalta does not believe are indicative of ongoing operating performance or
(iii) certain nonrecurring, unusual or infrequent items that have not otherwise
occurred within the last two years or we believe are not reasonably likely to
recur within the next two years. Free Cash Flow consists of cash provided by
(used for) operating activities less purchase of property, plant and equipment
plus interest proceeds on swaps designated as net investment hedges. Total net
leverage ratio consists of net debt divided by Adjusted EBITDA, with net debt
defined as total debt less cash and cash equivalents. We believe that making the
foregoing adjustments provides investors meaningful information to understand
our operating results and ability to analyze financial and business trends on a
period-to-period basis. The non-GAAP financial measures used by Axalta may
differ from similarly titled measures reported by other companies. Adjusted
EBITDA, Adjusted EBITDA margin, Adjusted Diluted EPS, adjusted net income, Free
Cash Flow, total net leverage ratio, tax rate, as adjusted, and Adjusted EBIT
should not be considered as alternatives to net sales, net income (loss), income
(loss) from operations or any other financial measures derived in accordance
with GAAP. These non-GAAP financial measures have important limitations as
analytical tools and should be considered in conjunction with, and not as
substitutes for, our results as reported under GAAP. This release includes a
reconciliation of certain non-GAAP financial measures with the most directly
comparable financial measures calculated in accordance with GAAP. Axalta does
not provide a reconciliation for Adjusted EBITDA, Adjusted Diluted EPS, tax
rate, as adjusted, or Free Cash Flow on a forward-looking basis because the
information necessary to calculate a meaningful or accurate estimation of
reconciling items is not available without unreasonable effort. For example,
such reconciling items include the impact of foreign currency exchange gains or
losses, gains or losses that are unusual or nonrecurring in nature, as well as
discrete taxable events. These items are uncertain, depend on various factors
and may have a substantial and unpredictable impact on our GAAP results.
                                                                                
   Segment Financial Measures                                                   
                                                                                
The primary measure of segment operating performance is Adjusted EBITDA, which
is a key metric that is used by management to evaluate business performance in
comparison to budgets, forecasts and prior year financial results and that
management believes reflects Axalta’s core operating performance. As we do not
measure segment operating performance
                                       3                                        
based on net income, a reconciliation of this non-GAAP financial measure with
the most directly comparable financial measure calculated in accordance with
GAAP is not available.
                                                                                
  Defined Terms                                                                 
                                                                                
All capitalized terms contained within this release that are not otherwise
defined herein have been previously defined in our filings with the SEC.
                                                                                
  Rounding                                                                      
                                                                                
Certain amounts may not foot or crossfoot due to rounding. Additionally, certain
percentages may not recalculate due to rounding.
                                                                                
  General Restrictions                                                          
                                                                                
This communication is not for release, publication, or distribution, in whole or
in part, in or into, directly or indirectly, any jurisdiction in which such
release, publication, or distribution would be unlawful.

This communication is not a prospectus and the information in this communication
is not intended to be complete. This communication is for informational purposes
only and is not intended to be and shall not constitute a solicitation of any
vote or approval, or an offer to buy or sell, or the solicitation of an offer to
buy or sell, any securities, or an invitation or recommendation to subscribe
for, acquire or buy securities of Axalta or AkzoNobel or any other financial
products or securities, in any place or jurisdiction, nor shall there be any
offer, solicitation or sale of securities in any jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such jurisdiction. No offer of
securities shall be made except by means of a prospectus meeting the
requirements of Section 10 of the U.S. Securities Act of 1933, as amended (the
“Securities Act”).

Any decision to purchase, subscribe for, otherwise acquire, sell or otherwise
dispose of any securities must be made only on the basis of the information
contained in and incorporated by reference into the prospectus with respect to
the shares to be allotted by AkzoNobel in the Proposed Merger, which was
published on June 24, 2026 and supplemented on July 22, 2026.

The distribution of this communication may, in some countries, be restricted by
law or regulation. Accordingly, persons who come into possession of this
document should inform themselves of and observe these restrictions. To the
fullest extent permitted by applicable law, Axalta and AkzoNobel disclaim any
responsibility or liability for the violation of any such restrictions by any
person. Neither Axalta, nor AkzoNobel, nor any of their advisors assume any
responsibility for any violation by any person of any of these restrictions.
Shareholders of Axalta and AkzoNobel, respectively, with any doubt as to their
position should consult an appropriate professional advisor without delay.

This communication is addressed to and directed only at (i) persons who are
outside the United Kingdom, (ii) persons having professional experience in
matters relating to investments falling within Article 19(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the
“Order”), (iii) persons falling within Article 49(2)(a) to (d) of the Order, or
(iv) persons to whom it may otherwise lawfully be communicated pursuant to the
Order (all such persons together being referred to as, “Relevant Persons”). This
communication is directed only at Relevant Persons. Other persons should not act
or rely on this communication or any of its contents. Any investment or
investment activity to which this communication relates is available only to
Relevant Persons and will be engaged in only with such persons. Solicitations
resulting from this communication will only be responded to if the person
concerned is a Relevant Person.
                                                                                
  Additional Information and Where to Find It                                   
                                                                                
In connection with the Proposed Merger between Axalta and AkzoNobel, AkzoNobel
filed with the SEC a registration statement on Form F-4 on May 27, 2026, as
amended on June 18, 2026, which included a proxy statement of Axalta that also
constitutes a prospectus with respect to the shares to be offered by AkzoNobel
in the Proposed Merger. The registration statement was declared effective by the
SEC on June 23, 2026. In connection with the proposed transaction, on June 24,
2026, Axalta filed with the SEC a definitive proxy statement and, on or about
June 24, 2026, Axalta commenced mailing the definitive proxy statement to its
holders of record as of June 11, 2026. On August 5, 2026, shareholders at the
Extraordinary General Meeting of AkzoNobel and the Special General Meeting of
Axalta, respectively, voted in favor of all resolutions related to the Proposed
Merger. Each of Axalta and AkzoNobel will also file other relevant documents in
connection with the Proposed Merger. This communication is not a substitute for
any registration statement, proxy statement/prospectus or other documents Axalta
and/or AkzoNobel may file with the SEC or any other competent regulator in
connection with the Proposed Merger. This communication does not contain all the
information that should be considered concerning the Proposed Merger and is not
intended to form the basis of any investment decision or any other decision in
respect of the Proposed Merger. BEFORE MAKING ANY VOTING OR INVESTMENT
DECISIONS, INVESTORS, STOCKHOLDERS AND
                                       4                                        
SHAREHOLDERS OF AXALTA AND AKZONOBEL ARE URGED TO READ CAREFULLY AND IN THEIR
ENTIRETY THE PROXY STATEMENT/PROSPECTUS, AS APPLICABLE, AND ANY OTHER RELEVANT
DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY
AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, IN CONNECTION WITH THE PROPOSED
TRANSACTION WHEN THEY BECOME AVAILABLE, AS THEY CONTAIN OR WILL CONTAIN
IMPORTANT INFORMATION ABOUT AXALTA, AKZONOBEL, THE PROPOSED TRANSACTION AND
RELATED MATTERS. The registration statement and proxy statement/prospectus and
other relevant documents filed by Axalta and AkzoNobel with the SEC are
available free of charge at the SEC’s website at www.sec.gov. In addition,
investors and shareholders will be able to obtain free copies of the proxy
statement/prospectus and other documents filed with the SEC from Axalta’s
investor relations webpage at https://ir.axalta.com/sec-filings/all-sec-filings
or from AkzoNobel’s investor relations webpage at
https://www.akzonobel.com/en/investors/all-sec-filings.

The contents of this communication should not be construed as financial, legal,
business, investment, tax or other professional advice. Each recipient should
consult with its own professional advisors for any such matter and advice
                                                                                
  About Axalta Coating Systems                                                  
                                                                                
Axalta is a global leader in the coatings industry, providing customers with
innovative, colorful, beautiful and sustainable coatings solutions. From light
vehicles, commercial vehicles and refinish applications to electric motors,
building facades and other industrial applications, our coatings are designed to
prevent corrosion, increase productivity and enhance durability. With more than
150 years of experience in the coatings industry, the global team at Axalta
continues to find ways to serve our more than 100,000 customers in over 140
countries better every day with the finest coatings, application systems and
technology. For more information visit axalta.com and follow us @axalta on X.
                                       5                                        
                                                                                
  Financ…                                                                       
  Statem…                                                                       
  Tables                                                                        
  AXALTA                                                                        
  COATING                                                                       
  SYSTEMS                                                                       
  LTD.                                                                          
  Conden…                                                                       
  Consol…                                                                       
  Statem…                                                                       
  of                                                                            
  Operat…                                                                       
  (Unaud…                                                                       
  (In                                                                           
  millio…                                                                       
  except                                                                        
  per                                                                           
  share                                                                         
  data)                                                                         
                 Three                              Nine                        
                Months                            Months                        
                 Ended                             Ended                        
             September                          Septemb…                        
                   30,                               30,                        
                  2026           2025               2026           2025         
  Net                $  1,311       $  1,288           $  3,911       $  3,855  
  sales                                                                         
  Cost of                                                                       
  goods                   877            838              2,596          2,515  
  sold                                                                          
  Sellin…                                                                       
  general                                                                       
  and                     201            197                614            607  
  admini…                                                                       
  expens…                                                                       
  Other                                                                         
  operat…                  24              6                 92             32  
  charges                                                                       
  Resear…                                                                       
  and                      18             18                 54             55  
  develo…                                                                       
  expens…                                                                       
  Amorti…                                                                       
  of                       26             25                 77             73  
  acquir…                                                                       
  intang…                                                                       
  Income                                                                        
  from                    165            204                478            573  
  operat…                                                                       
  Intere…                                                                       
  expens…                  37             45                112            134  
  net                                                                           
  Other                                                                         
  expense                   —              4                 -1             12  
  (incom…                                                                       
  net                                                                           
  Income                                                                        
  before                  128            155                367            427  
  income                                                                        
  taxes                                                                         
  Provis…                                                                       
  for                      33             45                 92            108  
  income                                                                        
  taxes                                                                         
  Net                      95            110                275            319  
  income                                                                        
  Less:                                                                         
  Net                                                                           
  income                                                                        
  attrib…                   —              —                  1              1  
  to                                                                            
  noncon…                                                                       
  intere…                                                                       
  Net                                                                           
  income                                                                        
  attrib…            $     95       $    110           $    274       $    318  
  to                                                                            
  common                                                                        
  shareh…                                                                       
  Basic                                                                         
  net                                                                           
  income             $   0.44       $   0.51           $   1.28       $   1.47  
  per                                                                           
  share                                                                         
  Diluted                                                                       
  net                                                                           
  income             $   0.44       $   0.51           $   1.28       $   1.46  
  per                                                                           
  share                                                                         
  Basic                                                                         
  weight…                                                                       
  average               214.0          215.0              213.9          216.9  
  shares                                                                        
  outsta…                                                                       
  Diluted                                                                       
  weight…                                                                       
  average               215.1          215.9              214.8          217.9  
  shares                                                                        
  outsta…                                                                       
                                                                                
                                       6                                        
                                                                                
  AXALTA COATING                                                                
  SYSTEMS LTD.                                                                  
  Condensed                                                                     
  Consolidated                                                                  
  Balance Sheets                                                                
  (Unaudited)                                                                   
  (In millions,                                                                 
  except per share                                                              
  data)                                                                         
  Assets                                                                        
  Current assets:      September 30, 2026            December 31, 2025          
 ────────────────────────────────────────────────────────────────────────────── 
  Cash and cash        $                      650    $                     657  
  equivalents                                                                   
  Restricted cash                               6                            3  
  Accounts and                                                                  
  notes receivable,                         1,366                        1,229  
  net                                                                           
  Inventories                                 849                          756  
  Prepaid expenses                                                              
  and other current                           192                          170  
  assets                                                                        
  Total current                             3,063                        2,815  
  assets                                                                        
  Property, plant                                                               
  and equipment,                            1,319                        1,299  
  net                                                                           
  Goodwill                                  1,762                        1,795  
  Identifiable                              1,056                        1,147  
  intangibles, net                                                              
  Other assets                                547                          543  
  Total assets         $                    7,747    $                   7,599  
  Liabilities,                                                                  
  Shareholders’                                                                 
  Equity                                                                        
  Current                                                                       
  liabilities:                                                                  
  Accounts payable     $                      780    $                     637  
  Current portion                             519                           20  
  of borrowings                                                                 
  Other accrued                               701                          712  
  liabilities                                                                   
  Total current                             2,000                        1,369  
  liabilities                                                                   
  Long-term                                 2,476                        3,179  
  borrowings                                                                    
  Accrued pensions                            225                          238  
  Deferred income                             182                          171  
  taxes                                                                         
  Other liabilities                           198                          249  
  Total liabilities                         5,081                        5,206  
  Shareholders’                                                                 
  equity:                                                                       
  Common shares,                                                                
  $1.00 par,                                                                    
  1,000.0 shares                                                                
  authorized, 255.7                                                             
  and 255.1 shares                                                              
  issued at                                   256                          255  
  September 30,                                                                 
  2026 and                                                                      
  December 31,                                                                  
  2025,                                                                         
  respectively                                                                  
  Capital in excess                         1,637                        1,621  
  of par                                                                        
  Retained earnings                         2,329                        2,055  
  Treasury shares,                                                              
  at cost, 41.7                                                                 
  shares at                                                                     
  both September                           -1,202                       -1,202  
  30, 2026 and                                                                  
  December 31,                                                                  
  2025                                                                          
  Accumulated other                                                             
  comprehensive                              -400                         -383  
  loss                                                                          
  Total Axalta                                                                  
  shareholders’                             2,620                        2,346  
  equity                                                                        
  Noncontrolling                               46                           47  
  interests                                                                     
  Total                                                                         
  shareholders’                             2,666                        2,393  
  equity                                                                        
  Total liabilities                                                             
  and shareholders’    $                    7,747    $                   7,599  
  equity                                                                        
                                                                                
                                       7                                        
                                                                                
  AXALTA COATING SYSTEMS LTD.                                                   
  Condensed Consolidated Statements                                             
  of Cash Flows (Unaudited)              Nine Months Ended                      
  (In millions)                          September 30,                          
  Operating activities:                  2026                       2025        
 ────────────────────────────────────────────────────────────────────────────── 
  Net income                             $                   275    $      319  
  Adjustment to reconcile net income                                            
  to                                                                            
  cash provided by operating                                                    
  activities:                                                                   
  Depreciation and amortization                              233           218  
  Amortization of deferred financing                                            
  costs                                                        6             6  
  and original issue discount                                                   
  Deferred income taxes                                       24            28  
  Realized and unrealized foreign                                               
  exchange                                                    -8            31  
  (gains) losses, net                                                           
  Stock-based compensation                                    23            19  
  Interest income on swaps designated                                           
  as                                                          -9            -9  
  net investment hedges                                                         
  Other non-cash, net                                         -2             8  
  Changes in operating assets and                                               
  liabilities:                                                                  
  Trade accounts and notes receivable                       -132           -48  
  Inventories                                                -99           -53  
  Prepaid expenses and other assets                          -75          -132  
  Accounts payable                                           146           -15  
  Other accrued liabilities                                    2           -71  
  Other liabilities                                          -29             4  
  Cash provided by operating                                 355           305  
  activities                                                                    
  Investing activities:                                                         
  Acquisitions, net of cash acquired                          -8            -6  
  Purchase of property, plant and                           -144          -138  
  equipment                                                                     
  Interest proceeds on swaps                                                    
  designated as                                                9             9  
  net investment hedges                                                         
  Proceeds received on loans to                                8             6  
  customers                                                                     
  Other investing activities, net                             -3             7  
  Cash used for investing activities                        -138          -122  
  Financing activities:                                                         
  Payments on long-term borrowings                          -211           -25  
  Purchases of common stock                                    —          -165  
  Net cash flows associated with                              -7            -3  
  stock-based awards                                                            
  Other financing activities, net                             -3            -2  
  Cash used for financing activities                        -221          -195  
  Decrease in cash                                            -4           -12  
  Effect of exchange rate changes on                           —            26  
  cash                                                                          
  Cash at beginning of period                                660           596  
  Cash at end of period                  $                   656    $      610  
  Cash at end of period                                                         
  reconciliation:                                                               
  Cash and cash equivalents              $                   650    $      606  
  Restricted cash                                              6             4  
  Cash at end of period                  $                   656    $      610  
                                                                                
                                       8                                        
The following table reconciles net income to EBITDA, Adjusted EBITDA and segment
Adjusted EBITDA for the periods presented (in millions):
                                                                                
      …                     …                                                   
      …                     …              N…                         Y…        
      …                     …              M…                         E…        
      …                     …              E…                         D…        
      …                     …              S…                         3…        
      …          …          …         …    3…        2…               2…        
 ────────────────────────────────────────────────────────────────────────────── 
      $  …       $  …       $  3…          $   …           $  …       $   …     
         …          …          1…              …              …           …     
         …          …          1…              …              …           …     
         …          …          3…              …              …           …     
         …          …          9…              …              …           …     
         5          2          12              …              …           …     
         …          5          97              …              …           …     
         1          1           5              5              6           6     
         2          4          11              7              …           …     
         3          3          14              …              9           …     
         8          6          29              …              …           …     
         —          …          -1              —              …           …     
         …          4           1              1              4           4     
      $  …       $  …       $  1…          $   …           $  …       $   …     
      $  …       $  …       $  5…          $   …           $  …       $   …     
         …  %       …  %       6…  %           …  %           …  %        …  %  
         …  %       …  %       2…  %           …  %           …  %        …  %  
                                                                                
      $  …       $  …       $  7…          $   …           $  …       $   …     
         …          …          3…              …              …           …     
      $  …       $  …       $  1…          $   …           $  …       $   …     
                                                                                
                                                                                
         Represents expenses and associated changes to estimates related to     
         employee termination benefits, consulting, legal and other             
  (a)    employee-related costs associated with restructuring programs and      
         other employee-related costs. We do not consider these amounts         
         indicative of our ongoing operating performance.                       
         Represents merger and acquisition-related expenses, including costs    
  (b)    related to financial, tax and legal advisory services, associated      
         with both consummated and unconsummated transactions, all of which we  
         do not consider indicative of our ongoing operating performance.       
         Represents costs related to the closure of certain manufacturing       
  (c)    sites, including impairment charges, which we do not consider          
         indicative of our ongoing operating performance.                       
         Represents foreign exchange losses resulting from the remeasurement    
  (d)    of assets and liabilities denominated in foreign currencies, net of    
         the impacts of our foreign currency instruments used to hedge our      
         balance sheet exposures.                                               
  (e)    Represents the non-cash, non-service cost components of long-term      
         employee benefit costs.                                                
  (f)    Represents non-cash impacts associated with stock-based compensation.  
         Represents non-recurring income related to the sales of certain fixed  
  (g)    assets, which are not considered indicative of our ongoing             
         performance.                                                           
         Represents (benefits) costs for certain non-operational or non-cash    
  (h)    (gains) losses, net, unrelated to our core business and which we do    
         not consider indicative of our ongoing operating performance.          
                                                                                
                                       9                                        
The following table reconciles net income to adjusted net income for the periods
presented (in millions, except per share data):
                                                                                
                        Three                              Nine                 
                       Months                            Months                 
                        Ended                             Ended                 
                    September                         September                 
              2026        30,    2025           2026        30,    2025         
 ────────────────────────────────────────────────────────────────────────────── 
  Net         $            95    $       110    $           275    $       319  
  income                                                                        
  Less:                                                                         
  Net                                                                           
  income                                                                        
  attribu…                  —              —                  1              1  
  to                                                                            
  noncont…                                                                      
  interes…                                                                      
  Net                                                                           
  income                                                                        
  attribu…                 95            110                274            318  
  to                                                                            
  common                                                                        
  shareho…                                                                      
  Termina…                                                                      
  benefits                                                                      
  and                       5              2                 11             22  
  other                                                                         
  employe…                                                                      
  costs(a)                                                                      
  Merger                                                                        
  and                      19              5                 76             11  
  acquisi…                                                                      
  costs(b)                                                                      
  Acceler…                                                                      
  depreci…                                                                      
  and site                  1              1                  5              8  
  closure                                                                       
  costs(c)                                                                      
  Other                    -2             -2                  2             -1  
  adjustm…                                                                      
  Amortiz…                                                                      
  of                       26             25                 77             73  
  acquired                                                                      
  intangi…                                                                      
  Total                    49             31                171            113  
  adjustm…                                                                      
  Income                                                                        
  tax                       8             -3                 36             19  
  provisi…                                                                      
  impacts…                                                                      
  Adjusted                                                                      
  net         $           136    $       144    $           409    $       412  
  income                                                                        
  Adjusted                                                                      
  diluted                                                                       
  net         $          0.63    $      0.67    $          1.91    $      1.89  
  income                                                                        
  per                                                                           
  share                                                                         
  Diluted                                                                       
  weighted                                                                      
  average               215.1          215.9              214.8          217.9  
  shares                                                                        
  outstan…                                                                      
                                                                                
                                                                                
         Represents expenses and associated changes to estimates related to     
         employee termination benefits, consulting, legal and other             
  (a)    employee-related costs associated with restructuring programs and      
         other employee-related costs. We do not consider these amounts         
         indicative of our ongoing operating performance.                       
         Represents merger and acquisition-related expenses, including costs    
  (b)    related to financial, tax and legal advisory services, associated      
         with both consummated and unconsummated transactions, all of which we  
         do not consider indicative of our ongoing operating performance.       
         Represents incremental depreciation expense resulting from truncated   
         useful lives of the assets impacted by our manufacturing footprint     
  (c)    assessments and costs related to the closure of certain manufacturing  
         sites, including impairment charges, which we do not consider          
         indicative of our ongoing operating performance.                       
         Represents (benefits) costs for certain non-operational or non-cash    
  (d)    (gains) losses, net, unrelated to our core business and which we do    
         not consider indicative of our ongoing operating performance.          
  (e)    Represents non-cash amortization expense for intangible assets         
         acquired through business combinations or asset acquisitions.          
         The income tax impacts are determined using the applicable rates in    
         the taxing jurisdictions in which expense or income occurred and       
         includes both current and deferred income tax expense (benefit) based  
  (f)    on the nature of the non-GAAP performance measure. Additionally, the   
         income tax impact includes the removal of discrete income tax impacts  
         within our effective tax rate which were benefits of $0 million and    
         $12 million and expenses of $10 million and $6 million for the three   
         and nine months ended September 30, 2026 and 2025, respectively.       
                                                                                
                                       10                                       
The following table reconciles cash provided by operating activities to free
cash flow for the periods presented (in millions):
                                                                                
           T…                  T…                T…                N…           
           M…                  M…                M…                M…           
           E…                  E…                E…                E…           
           M…                  J…                S…                S…           
       2…  3…    2…        2…  3…    …        …  3…    …        …  3…    …      
 ────────────────────────────────────────────────────────────────────────────── 
  …                                                                             
  …                                                                             
  …    $   68    $   26    $   1…    $  1…    $  1…    $  1…    $  3…    $  3…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …        -…        -…        -…       -…       -…       -…       -…       -…  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …         3         3         3        4        3        2        9        9  
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …                                                                             
  …    $   21    $   -…    $   1…    $  1…    $  92    $  89    $  2…    $  1…  
  …                                                                             
                                                                                
                                       11                                       
The following table reconciles income from operations to adjusted EBIT for the
periods presented (in millions):
                                                                                
                           Three                             Nine               
                          Months                           Months               
                           Ended                            Ended               
                       September                        September               
               2026          30,    2025         2026         30,    2025       
 ────────────────────────────────────────────────────────────────────────────── 
  Income                                                                        
  from         $             165    $     204    $            478    $     573  
  operatio…                                                                     
  Other                                                                         
  expense                      —            4                  -1           12  
  (income),                                                                     
  net                                                                           
  Total                      165          200                 479          561  
  Terminat…                                                                     
  benefits                                                                      
  and other                    5            2                  11           22  
  employee…                                                                     
  costs(a)                                                                      
  Merger                                                                        
  and                         19            5                  76           11  
  acquisit…                                                                     
  costs(b)                                                                      
  Accelera…                                                                     
  deprecia…                                                                     
  and site                     1            1                   5            8  
  closure                                                                       
  costs(c)                                                                      
  Other                       -2           -2                   2           -1  
  adjustme…                                                                     
  Amortiza…                                                                     
  of                          26           25                  77           73  
  acquired                                                                      
  intangib…                                                                     
  Adjusted     $             214    $     231    $            650    $     674  
  EBIT                                                                          
                                                                                
                                                                                
         Represents expenses and associated changes to estimates related to     
         employee termination benefits, consulting, legal and other             
  (a)    employee-related costs associated with restructuring programs and      
         other employee-related costs. We do not consider these amounts         
         indicative of our ongoing operating performance.                       
         Represents merger and acquisition-related expenses, including costs    
  (b)    related to financial, tax and legal advisory services, associated      
         with both consummated and unconsummated transactions, all of which we  
         do not consider indicative of our ongoing operating performance.       
         Represents incremental depreciation expense resulting from truncated   
         useful lives of the assets impacted by our manufacturing footprint     
  (c)    assessments and costs related to the closure of certain manufacturing  
         sites, including impairment charges, which we do not consider          
         indicative of our ongoing operating performance.                       
         Represents (benefits) costs for certain non-operational or non-cash    
  (d)    (gains) losses, net, unrelated to our core business and which we do    
         not consider indicative of our ongoing operating performance.          
  (e)    Represents non-cash amortization expense for intangible assets         
         acquired through business combinations or asset acquisitions.          
                                                                                
                                       12                                       

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AXTA/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.